Cantor Fitzgerald Reiterates Overweight on Surgery Partners, Maintains $43 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Surgery Partners (NASDAQ:SGRY) and maintained a $43 price target.
March 05, 2024 | 5:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Surgery Partners and maintained a $43 price target.
The reiteration of an Overweight rating and the maintenance of a $43 price target by a reputable analyst could signal confidence in Surgery Partners' future performance, potentially influencing investor sentiment positively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100